Please ensure Javascript is enabled for purposes of website accessibility

    BNY Mellon Innovators ETF (BKIV)

    • CUSIP 09661T818
    • NAV  $ 24.51 As of  09/22/23
    • CHG  $ -0.04 (-0.16 %)
    • MKT PRICE  $24.52 As of  09/22/23
    • CHG  $-0.05 (-0.20 %)
    • TOT EXPENSE RATIO  0.50% 
    Overview

    Why invest in this Fund?

    • The fund seeks long-term capital growth by investing in equity securities of U.S. innovation-driven companies, across the market capitalization spectrum.
    • The fund considers companies to be innovative that, through their intellectual property, provide leading edge products or services that are transformative or disruptive to existing business practices.
    • Provides a growth-oriented investment for investors interested in leading edge companies with sustainable growth prospects.
    • Liquid ETF structure allows investors to buy or sell any time the market is open.
    INCEPTION DATE
    05/16/23
    NET ASSETS
    $9,803,747  As of  09/22/23
    NUMBER OF SHARES OUTSTANDING
    400,001  As of  09/22/23
    DIVIDEND YIELD (ANNUALIZED)
    0.16% As of  08/31/23
    MARKET PRICE 52-WEEK HIGH
    $29.03  As of  07/18/23
    MARKET PRICE 52-WEEK LOW
    $24.52  As of  09/22/23
    DISTRIBUTION FREQUENCY
    Annually
    Morningstar Category
    Large Growth
    Number of Holdings
    53 As of  08/31/23
    PRICE/EARNINGS RATIO
    39.25 As of  08/31/23
    PRICE/BOOK RATIO
    5.73 As of  08/31/23
    WEIGHTED AVERAGE MARKET CAP
    (in millions)
    $209,153 As of  08/31/23
    SUB-ASSET CLASS
    Mid Cap - Growth
    EXCHANGE
    NASDAQ

    NAV - A fund's NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding.

    Market Price - The market price is the most recent official closing price for the listed exchange.

    Price/Earnings Ratio - Price-to-earnings (P/E) is the ratio of the market price of a firm’s common stock to its current (or predicted) earnings per share.

    Price/Book Ratio - Price-to-book value (P/B) is a ratio used to compare a stock's market value with its book value. It is calculated by dividing the current closing price of the stock by the latest quarter’s book value (assets minus liabilities).

    Weighted Avg Market Cap - Weighted average market cap is the average market capitalization of corporations in a fund or index, weighted by the percentage of the holding in the fund or index.

    Portfolio Managers

    • John Porter

      John Porter

      CIO, Head of Equity, Newton Investment Management North America, LLC

      Since Fund Inception
    • Edward R. Walter

      Edward R. Walter, CFA

      Research Analyst, Newton Investment Management North America, LLC

      Since Fund Inception
    Performance

    Daily Statistics

    As of  09/22/23 NAME 30-DAY
    SEC YIELD
    (WITHOUT WAIVER)     		30-DAY
    SEC YIELD
    (WITH WAIVER)     		30-DAY MEDIAN 
    BID/ASK 
    SPREAD     		PREVIOUS DAY
    VOLUME     		20-DAY AVG 
    VOLUME     		PREMIUM/ 
    DISCOUNT     		SINCE
    INCEPTION
    Total Return
    (NAV)
    BNY Mellon Innovators ETF
    		-0.32% -0.32% 0.19% 0 441 0.05% -1.96%

    Past performance is no guarantee of future results.

     

    30-Day SEC Yield - 30-Day SEC Yield is based upon dividends per share from net investment income during the past 30 days, divided by the period ended maximum offering price per share and annualized. Unsubsidized yield displays what the fund's 30-Day SEC Yield would have been had no fee waiver or expense reimbursement been in place during the period.

    30-Day Median Bid-Ask Spread - Gives investors the midpoint within the spread between an ETF’s selling price and buying price. It is calculated over the last 30 days in 10 second intervals by dividing the difference between the bid (sell price) and offer (buy price) by the midpoint of the National Best Bid Offer (NBBO) and identifying the median of those values.

    20-Day Avg Volume - 20-Day Average Volume is the sum of last 20 days of trading volume divided by 20 days.

    Premium / Discount - The amount the fund is trading above or below the reported NAV expressed as a percentage of the NAV. When the fund's market price is greater than the fund's NAV, it is said to be trading at a "Premium" and the percentage is expressed as a positive number. When the fund's market price is less than the fund's NAV, it is said to be trading at a "Discount" and the percentage is expressed as a negative number.

    Total Returns

    Click here for NAV Returns 

    Month End

    MARKET PRICE
    Average Annual
    As of 08/31/23
    Name 3 MO
    08/31/23     		YTD
    08/31/23     		1 YR 3 YRS 5 YRS 10 YRS Since Inception
    08/31/23
    BNY Mellon Innovators ETF
    BKIV
    		5.01 - - - - - 8.16
    Russell 3000 Growth Index
    		9.35 30.97 21.03 7.89 13.04 15.11 -

    Quarter End

    MARKET PRICE
    Average Annual
    As of 06/30/23
    Name 3 MO
    06/30/23     		YTD
    06/30/23     		1 YR 3 YRS 5 YRS 10 YRS Since Inception
    06/30/23
    BNY Mellon Innovators ETF
    BKIV
    		- - - - - - 10.48
    Russell 3000 Growth Index
    		12.47 28.05 26.60 13.24 14.39 15.26 -

    The performance data quoted represents past performance, which is no guarantee of future results. Share price, yield and investment return fluctuate and an investor's shares may be worth more or less than original cost upon redemption. Current performance may be lower or higher than the performance quoted. Returns less than 1 year are not annualized.

    Market Price performance is calculated using the most recent NASDAQ Official Closing Price. Market Price returns do not represent investors’ returns had they traded shares at other times.

    The Russell 3000® Growth Index measures the performance of the broad growth segment of the U.S. equity universe. It includes those Russell 3000 companies with relatively higher price-to-book ratios, higher forecasted growth rates and higher sales per share historical growth. The index is completely reconstituted annually to ensure new and growing equities are included and that the represented companies continue to reflect growth characteristics. An investor cannot invest directly in any index.

    The fund currently does not have a stated benchmark to measure performance against, however comparison of fund performance to an appropriate index indicates how the fund's returns compare with those of a broad measure of market performance. Past performance is no guarantee of future results.

    Growth of $10,000 Investment

    Historical NAV and Market Price

      Historical Premium/Discount

      Fees & Expenses

      Prospectus Fee Table Expense Ratios

      Fees as stated in the prospectus  Fee Description Total Expense Ratio (%)
      Management Fee 0.50%
      Other Expenses 0.00%
      Total Expenses 0.50%

      The Total Expenses is the actual fund expense ratio applicable to investors.

      Portfolio

      Portfolio Manager/Sub-Investment Adviser

      The fund's investment adviser is BNY Mellon ETF Investment Adviser, LLC (Adviser) and the fund's sub-adviser is Newton Investment Management North America LLC (NIMNA), an affiliate of the Adviser.

      John Porter and Edward Walter are the fund's primary portfolio managers, positions they have held since the fund's inception in May 2023. Mr. Porter is Chief Investment Officer and Head of Equity at NIMNA. Mr. Walter is a portfolio manager and member of NIMNA's research team. Each portfolio manager is jointly and primarily responsible for the day-to-day management of the fund's portfolio.

      Top Holdings

      Download Total Holdings
      As of 09/22/23
      Holdings % Portfolio Weight
      NVIDIA CORP 6.99
      ALPHABET INC-CL C 5.56
      CACTUS INC - A 3.76
      COSTAR GROUP INC 3.73
      ARES MANAGEMENT CORP - A 3.24
      TWILIO INC - A 3.12
      INSMED INC 2.92
      NETFLIX INC 2.90
      SNOWFLAKE INC-CLASS A 2.89
      LULULEMON ATHLETICA INC 2.65
      ALIGN TECHNOLOGY INC 2.65
      BIOMARIN PHARMACEUTICAL I 2.40
      TRADE DESK INC/THE -CLASS 2.35
      REPLIGEN CORP 2.17
      ASCENDIS PHARMA A/S - ADR 2.17
      FRESHPET INC 2.12
      ILLUMINA INC 2.08
      DYNATRACE INC 2.03
      DEXCOM INC 1.93
      SAREPTA THERAPEUTICS INC 1.92
      INTUITIVE SURGICAL INC 1.90
      AIRBNB INC-CLASS A 1.89
      AZEK CO INC/THE 1.87
      BLOCK INC 1.86
      ALNYLAM PHARMACEUTICALS I 1.85
      MONGODB INC 1.82
      SHOPIFY INC - CLASS A 1.82
      LIBERTY MEDIA CORP-LIB-NE 1.75
      ALBEMARLE CORP 1.67
      TWIST BIOSCIENCE CORP 1.56
      INSPIRE MEDICAL SYSTEMS I 1.54
      DOUBLEVERIFY HOLDINGS INC 1.48
      CRINETICS PHARMACEUTICALS 1.34
      XENON PHARMACEUTICALS INC 1.33
      PRIVIA HEALTH GROUP INC 1.33
      DRAFTKINGS INC-CL A 1.29
      PELOTON INTERACTIVE INC-A 1.29
      CYTOKINETICS INC 1.27
      10X GENOMICS INC-CLASS A 1.23
      TRANSMEDICS GROUP INC 1.17
      DENALI THERAPEUTICS INC 1.17
      PACIFIC BIOSCIENCES OF CA 1.09
      IRHYTHM TECHNOLOGIES INC 1.07
      GARMIN LTD 1.05
      PROTHENA CORP PLC 1.03
      OUTSET MEDICAL INC 0.86
      VITAL FARMS INC 0.81
      DREYFUS INSTITUTIONAL PRE 0.77
      KEROS THERAPEUTICS INC 0.73
      CHEWY INC - CLASS A 0.55
      Net Current Assets 0.05

      % Portfolio Weight is calculated using the closing market price of each security from the prior business day.

      Holdings are subject to change. The holdings listed should not be considered recommendations to buy or sell a security.

      Asset Allocation

          Stats & Risks

          Main Risks

          ETFs trade like stocks, are subject to investment risk, including possible loss of principal.

          Equities are subject to market, market sector, market liquidity, issuer, and investment style risks, among other factors, to varying degrees. There can be no assurance that a company identified as an innovation-driven company by NIMNA will ultimately introduce a new product or service or that such product or service may not be significantly delayed or have the affect NIMNA anticipated. The returns on a portfolio of securities that are viewed by NIMNA as innovation-driven companies may trail the returns of a portfolio that is not limited to securities of innovation-driven companies. Investing only in securities of innovation-driven companies may affect the fund’s exposure to certain types of investments and may adversely impact the fund’s performance depending on whether such investments are in or out of favor in the market. The fund may significantly overweight or underweight certain companies, industries or market sectors, which may cause the fund's performance to be more or less sensitive to developments affecting those companies, industries or sectors.

          The fund is non-diversified, which means that the fund may invest a relatively high percentage of its assets in a limited number of issuers. Therefore, the fund's performance may be more vulnerable to changes in the market value of a single issuer or group of issuers and more susceptible to risks associated with a single economic, political or regulatory occurrence than a diversified fund.

          Although fund shares are listed for trading on an exchange and may be listed or traded on other U.S. and non-U.S. stock exchanges as well, there can be no assurance that an active trading market for such fund shares will develop or be maintained. Trading in fund shares may be halted due to market conditions or for reasons that, in the view of the listing exchange, make trading in fund shares inadvisable. In addition, trading in fund shares on an exchange is subject to trading halts caused by extraordinary market volatility pursuant to exchange "circuit breaker" rules. There can be no assurance that the requirements of the listing exchange necessary to maintain the listing of the fund will continue to be met or will remain unchanged or that fund shares will trade with any volume, or at all, on any stock exchange.

          Please refer to the prospectus for a more complete discussion of the fund's main risks.

          Distributions

          Dividend Schedule

          Declared
          Annually
          Distributed
          Annually
          Paid
          Annually
          Fiscal Year End
          Feb 28
          Literature

          Literature

          PRODUCT INFORMATION

          • Download
          • Share
          • Subscribe
          • Order
          BNY Mellon Thematic ETF Presentation Download

          Prospectus and Reports

          • Download
          • Share
          • Subscribe
          • Order
          Prospectus Download
          Summary Prospectus Download
          SAI Download
          1Q Fiscal Holdings Download

          Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or summary prospectus, if available, that contains that and other information about the fund, and read it carefully before investing.

          ETF shares are listed on an exchange, and shares are generally purchased and sold in the secondary market at market price. At times, the market price may be a premium or discount to the ETF's per share NAV. In addition, ETFs are subject to the risk that an active trading market for an ETF's shares may not develop or be maintained. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions. Any applicable brokerage commissions will reduce returns.

          ETFs trade like stocks, are subject to investment risk, including possible loss of principal. Equities are subject to market, market sector, market liquidity, issuer, and investment style risks, among other factors, to varying degrees. The risks of investing in this ETF typically reflect the risks associated with the types of instruments in which the ETF invests. Diversification cannot assure a profit or protect against loss.

          The fund will issue (or redeem) fund shares to certain institutional investors known as “Authorized Participants” (typically market makers or other broker-dealers) only in large blocks of fund shares known as “Creation Units.” BNY Mellon Securities Corporation (“BNYMSC”), a subsidiary of the BNY Mellon, serves as distributor of the fund. BNYMSC does not distribute fund shares in less than Creation Units, nor does it maintain a secondary market in fund shares. BNYMSC may enter into selected agreements with Authorized Participants for the sale of Creation Units of Creation Units of fund shares.

          Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.

          This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular investment, strategy, investment manager or account arrangement and should not serve as a primary basis for investment decisions.

          Please consult a legal, tax or investment professional in order to determine whether an investment product or service is appropriate for a particular situation.